Home>>Signaling Pathways>> Neuroscience>> 5-HT Receptor>>Frovatriptan succinate hydrate

Frovatriptan succinate hydrate Sale

(Synonyms: 罗曲普坦琥珀酸盐,(R)-Frovatriptan succinate hydrate; SB 209509 succinate hydrate; VML 251 succinate hydrate) 目录号 : GC38781

An agonist of 5-HT1B and 5-HT1D receptors

Frovatriptan succinate hydrate Chemical Structure

Cas No.:158930-17-7

规格 价格 库存 购买数量
1mg
¥274.00
现货
5mg
¥720.00
现货
10mg
¥1,170.00
现货

电话:400-920-5774 Email: sales@glpbio.cn

Customer Reviews

Based on customer reviews.

Sample solution is provided at 25 µL, 10mM.

产品文档

Quality Control & SDS

View current batch:

产品描述

Frovatriptan is an agonist of the serotonin (5-HT) receptor subtypes 5-HT1B and 5-HT1D (Kis = 2.51 and 3.98 nM, respectively).1,2 It is selective for 5-HT1B and 5-HT1D over 5-HT1A, 5-HT1E, 5-HT1F, 5-HT2A, 5-HT2C, 5-HT3, and 5-HT7 receptors, as well as dopamine D1, D2, and D3, histamine H1, and α1-adrenergic receptors (Kis = >50 nM). Frovatriptan induces contractions in human basilar arteries isolated post-mortem, coronary arteries from transplant recipient hearts, and coronary arteries from donor hearts unsuitable for transplantation (EC50s = 13.8, 41.69, and 15.49 nM, respectively).3 It increases carotid vascular resistance in closed-chest and open-chest anesthetized dogs (ED50s = 6 and 1 nmol/kg, i.v., respectively).4 Formulations containing frovatriptan have been used in the treatment of migraines.

1.Brown, A.M., Parsons, A.A., Raval, P., et al.SB 209509 (VML 251), a potent constrictor of rabbit basilar artery with high affinity and selectivity for human 5-HT1D receptorsBr. J. Pharmacol.119(Suppl 1)110P(1996) 2.Comer, M.B.Pharmacology of the selective 5-HT1B/1D agonist frovatriptanHeadache42(Suppl 2)S47-S53(2002) 3.Parsons, A.A., Raval, P., Smith, S., et al.Effects of the novel high-affinity 5-HT1B/1D-receptor ligand frovatriptan in human isolated basilar and coronary arteriesJ. Cardiovasc. Pharmacol.32(2)220-224(1998) 4.Parsons, A.A., Parker, S.G., Raval, P., et al.Comparison of the cardiovascular effects of the novel 5-HT1B/1D receptor agonist, SB 209509 (VML251), and sumatriptan in dogsJ. Cardiovasc. Pharmacol.30(1)136-141(1997)

Chemical Properties

Cas No. 158930-17-7 SDF
别名 罗曲普坦琥珀酸盐,(R)-Frovatriptan succinate hydrate; SB 209509 succinate hydrate; VML 251 succinate hydrate
Canonical SMILES O=C(O)CCC(O)=O.O=C(C1=CC2=C(NC3=C2C[C@H](NC)CC3)C=C1)N.O
分子式 C18H25N3O6 分子量 379.41
溶解度 DMF: 3mg/mL,DMSO: 10mg/mL,PBS (pH 7.2): 5mg/mL 储存条件 Store at -20°C
General tips 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。
为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。
Shipping Condition 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。

溶解性数据

制备储备液
1 mg 5 mg 10 mg
1 mM 2.6357 mL 13.1784 mL 26.3567 mL
5 mM 0.5271 mL 2.6357 mL 5.2713 mL
10 mM 0.2636 mL 1.3178 mL 2.6357 mL
  • 摩尔浓度计算器

  • 稀释计算器

  • 分子量计算器

质量
=
浓度
x
体积
x
分子量
 
 
 
*在配置溶液时,请务必参考产品标签上、MSDS / COA(可在Glpbio的产品页面获得)批次特异的分子量使用本工具。

计算

动物体内配方计算器 (澄清溶液)

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
给药剂量 mg/kg 动物平均体重 g 每只动物给药体积 ul 动物数量
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方)
% DMSO % % Tween 80 % saline
计算重置